JENNIFER LILES: Open Payments
NPI 1174069611 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,673 in 83 payments from 16 companies in 2025. Trend: 2023 $1,352 · 2024 $1,426 · 2025 $1,673
Food & beverage: $1,673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $273 |
| AstraZeneca Pharmaceuticals LP | 4 | $193 |
| Lilly USA, LLC | 11 | $157 |
| Amgen Inc. | 9 | $153 |
| PFIZER INC. | 9 | $153 |
| Novo Nordisk Inc | 10 | $142 |
| Cepheid | 1 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Abbott Laboratories | 4 | $90 |
| UCB, Inc. | 3 | $66 |
Products named: RINVOQ, SAPHNELO, GeneXpert, MOUNJARO, NURTEC ODT, OTEZLA, Ozempic, FREESTYLE LIBRE 3.
Industry payments across AR — which companies pay providers there.
